Follow
Dominik Niopek
Dominik Niopek
Verified email at uni-heidelberg.de
Title
Cited by
Cited by
Year
CRISPR/Cas9‐mediated genome engineering: an adeno‐associated viral (AAV) vector toolbox
E Senís, C Fatouros, S Große, E Wiedtke, D Niopek, AK Mueller, K Börner, ...
Biotechnology journal 9 (11), 1402-1412, 2014
3512014
Engineering light-inducible nuclear localization signals for precise spatiotemporal control of protein dynamics in living cells
D Niopek, D Benzinger, J Roensch, T Draebing, P Wehler, R Eils, ...
Nature communications 5 (1), 4404, 2014
2662014
Optogenetic control of nuclear protein export
D Niopek, P Wehler, J Roensch, R Eils, B Di Ventura
Nature communications 7 (1), 10624, 2016
2442016
Engineered anti-CRISPR proteins for optogenetic control of CRISPR–Cas9
F Bubeck, MD Hoffmann, Z Harteveld, S Aschenbrenner, A Bietz, ...
Nature methods 15 (11), 924-927, 2018
2082018
Cell-specific CRISPR–Cas9 activation by microRNA-dependent expression of anti-CRISPR proteins
MD Hoffmann, S Aschenbrenner, S Grosse, K Rapti, C Domenger, ...
Nucleic acids research 47 (13), e75-e75, 2019
992019
Robust RNAi enhancement via human Argonaute-2 overexpression from plasmids, viral vectors and cell lines
K Börner, D Niopek, G Cotugno, M Kaldenbach, T Pankert, J Willemsen, ...
Nucleic acids research 41 (21), e199-e199, 2013
732013
Coupling Cas9 to artificial inhibitory domains enhances CRISPR-Cas9 target specificity
S Aschenbrenner, SM Kallenberger, MD Hoffmann, A Huck, R Eils, ...
Science advances 6 (6), eaay0187, 2020
622020
AAV vector-mediated in vivo reprogramming into pluripotency
E Senís, L Mosteiro, S Wilkening, E Wiedtke, A Nowrouzi, S Afzal, ...
Nature Communications 9 (1), 2651, 2018
552018
Creating functional engineered variants of the single-module non-ribosomal peptide synthetase IndC by T domain exchange
R Beer, K Herbst, N Ignatiadis, I Kats, L Adlung, H Meyer, D Niopek, ...
Molecular BioSystems 10 (7), 1709-1718, 2014
482014
Engineering and evolution of synthetic adeno-associated virus (AAV) gene therapy vectors via DNA family shuffling
E Kienle, E Senís, K Börner, D Niopek, E Wiedtke, S Grosse, D Grimm
Journal of visualized experiments: JoVE, 2012
482012
A robust and all-inclusive pipeline for shuffling of adeno-associated viruses
AK Herrmann, C Bender, E Kienle, S Grosse, J El Andari, J Botta, ...
ACS synthetic biology 8 (1), 194-206, 2018
392018
Optogenetic control of Neisseria meningitidis Cas9 genome editing using an engineered, light-switchable anti-CRISPR protein
MD Hoffmann, J Mathony, J Upmeier zu Belzen, Z Harteveld, ...
Nucleic acids research 49 (5), e29-e29, 2021
342021
Controlling cells with light and LOV
MD Hoffmann, F Bubeck, R Eils, D Niopek
Advanced Biosystems 2 (9), 1800098, 2018
312018
Enlightening allostery: designing switchable proteins by photoreceptor fusion
J Mathony, D Niopek
Advanced Biology 5 (5), 2000181, 2021
252021
Computational design of anti-CRISPR proteins with improved inhibition potency
J Mathony, Z Harteveld, C Schmelas, J Upmeier zu Belzen, ...
Nature chemical biology 16 (7), 725-730, 2020
232020
Leveraging implicit knowledge in neural networks for functional dissection and engineering of proteins
J Upmeier zu Belzen, T Bürgel, S Holderbach, F Bubeck, L Adam, ...
Nature Machine Intelligence 1 (5), 225-235, 2019
232019
Optogenetic control of nuclear protein import in living cells using light‐inducible nuclear localization signals (LINuS)
P Wehler, D Niopek, R Eils, B Di Ventura
Current protocols in chemical biology 8 (2), 131-145, 2016
182016
Are artists and engineers inventing the culture of tomorrow?
U Damm, B Hopfengärtner, D Niopek, P Bayer
Futures 48, 55-64, 2013
162013
Optogenetics and CRISPR: a new relationship built to last
J Mathony, MD Hoffmann, D Niopek
Photoswitching Proteins: Methods and Protocols, 261-281, 2020
142020
A hepatic GAbp-AMPK axis links inflammatory signaling to systemic vascular damage
K Niopek, BE Üstünel, S Seitz, M Sakurai, A Zota, F Mattijssen, X Wang, ...
Cell reports 20 (6), 1422-1434, 2017
142017
The system can't perform the operation now. Try again later.
Articles 1–20